Vimarsana
Biggest News Aggregation in the World

Page 2 - Marks Shearman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marks Shearman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marks Shearman Today - Breaking & Trending Today

Editas Medicine (NASDAQ:EDIT) Shares Down 4.3% - Vimarsana News

Editas Medicine (NASDAQ:EDIT) Shares Down 4.3%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) fell 4.3% during trading on Wednesday . The company traded as low as $7.70 and last traded at $7.70. 317,125 shares traded hands during trading, a decline of 82% from the average session volume of 1,730,446 shares. The stock had previously closed at $8.05. Analyst Upgrades and Downgrades […]

Source: wkrb13.com
Pictet Asset Management SA Raises Position in Editas Medicine, Inc. (NASDAQ:EDIT) - Vimarsana News

Pictet Asset Management SA Raises Position in Editas Medicine, Inc. (NASDAQ:EDIT)

Pictet Asset Management SA lifted its stake in Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 37.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 182,186 shares of the company’s stock after purchasing an additional 49,782 shares during the quarter. Pictet Asset Management […]

Pictet Asset Management SA Has $2.23 Million Holdings in Editas Medicine, Inc. (NASDAQ:EDIT) - Vimarsana News

Pictet Asset Management SA Has $2.23 Million Holdings in Editas Medicine, Inc. (NASDAQ:EDIT)

Pictet Asset Management SA raised its stake in shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) by 37.6% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 182,186 shares of the company’s stock after purchasing an additional 49,782 shares during the period. Pictet Asset Management SA […]

Editas Medicine, Inc. (NASDAQ:EDIT) Given Consensus Rating of "Hold" by Brokerages - Vimarsana News

Editas Medicine, Inc. (NASDAQ:EDIT) Given Consensus Rating of "Hold" by Brokerages

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting - Vimarsana News

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com